318 related articles for article (PubMed ID: 24137103)
1. Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE).
Mocroft A; Lundgren JD; Sabin ML; Monforte Ad; Brockmeyer N; Casabona J; Castagna A; Costagliola D; Dabis F; De Wit S; Fätkenheuer G; Furrer H; Johnson AM; Lazanas MK; Leport C; Moreno S; Obel N; Post FA; Reekie J; Reiss P; Sabin C; Skaletz-Rorowski A; Suarez-Lozano I; Torti C; Warszawski J; Zangerle R; Fabre-Colin C; Kjaer J; Chene G; Grarup J; Kirk O;
PLoS Med; 2013; 10(9):e1001510. PubMed ID: 24137103
[TBL] [Abstract][Full Text] [Related]
2. Late presentation for HIV care across Europe: update from the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study, 2010 to 2013.
; Mocroft A; Lundgren J; Antinori A; Monforte Ad; Brännström J; Bonnet F; Brockmeyer N; Casabona J; Castagna A; Costagliola D; De Wit S; Fätkenheuer G; Furrer H; Jadand C; Johnson A; Lazanas M; Leport C; Moreno S; Mussini C; Obel N; Post F; Reiss P; Sabin C; Skaletz-Rorowski A; Suarez-Loano I; Torti C; Warszawski J; Wittkop L; Zangerle R; Chene G; Raben D; Kirk O
Euro Surveill; 2015; 20(47):. PubMed ID: 26624933
[TBL] [Abstract][Full Text] [Related]
3. Estimating the burden of HIV late presentation and its attributable morbidity and mortality across Europe 2010-2016.
Late Presentation Working Groups in EuroSIDA and COHERE
BMC Infect Dis; 2020 Oct; 20(1):728. PubMed ID: 33028235
[TBL] [Abstract][Full Text] [Related]
4. Late presenters among persons with a new HIV diagnosis in Italy, 2010-2011.
Camoni L; Raimondo M; Regine V; Salfa MC; Suligoi B;
BMC Public Health; 2013 Mar; 13():281. PubMed ID: 23537210
[TBL] [Abstract][Full Text] [Related]
5. Clinical and immunological features of human immunodeficiency virus infection in patients from Bangkok, Thailand.
Wannamethee SG; Sirivichayakul S; Phillips AN; Ubolyam S; Ruxrungtham K; Hanvanich M; Phanuphak P
Int J Epidemiol; 1998 Apr; 27(2):289-95. PubMed ID: 9602412
[TBL] [Abstract][Full Text] [Related]
6. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100
[TBL] [Abstract][Full Text] [Related]
7. Geographical variation in disease progression in HIV-1 seroconverted injecting drug users in Europe?
Prins M; Brettle RP; Robertson JR; Hernández Aguado I; Broers B; Carré N; Goldberg DJ; Zangerle R; Coutinho RA; van den Hoek A
Int J Epidemiol; 1999 Jun; 28(3):541-9. PubMed ID: 10405862
[TBL] [Abstract][Full Text] [Related]
8. Late presentation of HIV infection: predictors of delayed diagnosis and survival in Eastern Sicily.
Celesia BM; Castronuovo D; Pinzone MR; Bellissimo F; Mughini MT; Lupo G; Scarpino MR; Gussio M; Palermo F; Cosentino S; Cacopardo B; Nunnari G
Eur Rev Med Pharmacol Sci; 2013 Aug; 17(16):2218-24. PubMed ID: 23893189
[TBL] [Abstract][Full Text] [Related]
9. Late presentation for HIV remains a major health issue in Spain: Results from a multicenter cohort study, 2004-2018.
Rava M; Domínguez-Domínguez L; Bisbal O; López-Cortés LF; Busca C; Antela A; González-Ruano P; Hernández C; Iribarren JA; Rubio R; Moreno S; Jarrín I;
PLoS One; 2021; 16(4):e0249864. PubMed ID: 33882093
[TBL] [Abstract][Full Text] [Related]
10. The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy era.
Mocroft A; Furrer HJ; Miro JM; Reiss P; Mussini C; Kirk O; Abgrall S; Ayayi S; Bartmeyer B; Braun D; Castagna A; d'Arminio Monforte A; Gazzard B; Gutierrez F; Hurtado I; Jansen K; Meyer L; Muñoz P; Obel N; Soler-Palacin P; Papadopoulos A; Raffi F; Ramos JT; Rockstroh JK; Salmon D; Torti C; Warszawski J; de Wit S; Zangerle R; Fabre-Colin C; Kjaer J; Chene G; Grarup J; Lundgren JD;
Clin Infect Dis; 2013 Oct; 57(7):1038-47. PubMed ID: 23921881
[TBL] [Abstract][Full Text] [Related]
11. Tuberculosis risk varies with the duration of HIV infection: a prospective study of European drug users with known date of HIV seroconversion.
van Asten L; Langendam M; Zangerle R; Hernández Aguado I; Boufassa F; Schiffer V; Brettle RP; Robertson JR; Fontanet A; Coutinho RA; Prins M
AIDS; 2003 May; 17(8):1201-8. PubMed ID: 12819522
[TBL] [Abstract][Full Text] [Related]
12. Correlates of Late Presentation to HIV care in a South Indian Cohort.
Rao S; Av S; Unnikrishnan B; Madi D; Shetty AK
Am J Trop Med Hyg; 2018 Nov; 99(5):1331-1335. PubMed ID: 30226140
[TBL] [Abstract][Full Text] [Related]
13. Frequency and correlates of late presentation for HIV infection in France: older adults are a risk group - results from the ANRS-VESPA2 Study, France.
Wilson Kd; Dray-Spira R; Aubrière C; Hamelin C; Spire B; Lert F;
AIDS Care; 2014; 26 Suppl 1():S83-93. PubMed ID: 24731147
[TBL] [Abstract][Full Text] [Related]
14. The effect of injecting drug use history on disease progression and death among HIV-positive individuals initiating combination antiretroviral therapy: collaborative cohort analysis.
Murray M; Hogg RS; Lima VD; May MT; Moore DM; Abgrall S; Bruyand M; D'Arminio Monforte A; Tural C; Gill MJ; Harris RJ; Reiss P; Justice A; Kirk O; Saag M; Smith CJ; Weber R; Rockstroh J; Khaykin P; Sterne JA;
HIV Med; 2012 Feb; 13(2):89-97. PubMed ID: 21819529
[TBL] [Abstract][Full Text] [Related]
15. Reconstruction and prediction of the HIV/AIDS epidemic among adults in the European Union and in the low prevalence countries of central and eastern Europe.
Downs AM; Heisterkamp SH; Brunet JB; Hamers FF
AIDS; 1997 Apr; 11(5):649-62. PubMed ID: 9108947
[TBL] [Abstract][Full Text] [Related]
16. Estimates of HIV incidence among persons testing for HIV using the sensitive/less sensitive enzyme immunoassy, New York City, 2001.
Nash D; Bennani Y; Ramaswamy C; Torian L
J Acquir Immune Defic Syndr; 2005 May; 39(1):102-11. PubMed ID: 15851920
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes of patients infected with HIV through use of injected drugs compared to patients infected through sexual transmission: late presentation, delayed anti-retroviral treatment and higher mortality.
Suárez-García I; Sobrino-Vegas P; Dalmau D; Rubio R; Iribarren JA; Blanco JR; Gutierrez F; Montero Alonso M; Bernal E; Vinuesa García D; Del Amo J;
Addiction; 2016 Jul; 111(7):1235-45. PubMed ID: 26890155
[TBL] [Abstract][Full Text] [Related]
18. Late HIV diagnosis and determinants of progression to AIDS or death after HIV diagnosis among injection drug users, 33 US States, 1996-2004.
Grigoryan A; Hall HI; Durant T; Wei X
PLoS One; 2009; 4(2):e4445. PubMed ID: 19214229
[TBL] [Abstract][Full Text] [Related]
19. Predictors of late presentation and advanced HIV disease among people living with HIV in Oman (2000-2019).
Elgalib A; Shah S; Al-Wahaibi A; Al-Habsi Z; Al-Fouri M; Lau R; Al-Kindi H; Al-Rawahi B; Al-Abri S
BMC Public Health; 2021 Nov; 21(1):2029. PubMed ID: 34742286
[TBL] [Abstract][Full Text] [Related]
20. Pre-AIDS mortality from natural causes associated with HIV disease progression: evidence from the European Seroconverter Study among injecting drug users.
Prins M; Hernández Aguado IH; Brettle RP; Robertson JR; Broers B; Carré N; Goldberg DJ; Zangerle R; Coutinho RA; van den Hoek A
AIDS; 1997 Nov; 11(14):1747-56. PubMed ID: 9386810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
